US drug-maker Ardelyx hires long-time Bristol Myers Squibb lawyer as next CLO.

{
  "signal_id": "a73fda3c-f9be-4877-b370-45771769cfaf",
  "signal_type": "news",
  "signal_subtype": "leaves",
  "detected_at": "2026-04-24T00:00:00+00:00",
  "company": {
    "name": "Bristol Myers Squibb",
    "domain": "bms.com"
  },
  "data": {
    "url": "https://www.globallegalpost.com/news/us-drug-maker-ardelyx-hires-long-time-bristol-myers-squibb-lawyer-as-next-clo-1022499171",
    "title": "US drug-maker Ardelyx hires long-time Bristol Myers Squibb lawyer as next CLO.",
    "contact": "Ettenberg",
    "excerpt": "US drug-maker Ardelyx hires long-time Bristol Myers Squibb lawyer as next CLO.\n\nFelecia Ettenberg is set to replace Elizabeth Grammer, who is retiring\n\n24 April 2026\n\nUS biopharma company Ardelyx has hired Felecia Ettenberg as chief legal officer, replacing Elizabeth Grammer in the role, who is retiring.\n\nEttenberg joins from Bristol Myers Squibb, where she was deputy general counsel for pipeline to patient global law. At Ardelyx she will oversee its legal, compliance, regulatory and government affairs functions.\n\nWaltham, Massachusetts-based Ardelyx is a commercial-stage biopharma company that develops medicines for a range of unmet needs, including bowel issues.\n\nMike Raab, president and chief executive officer of Ardelyx, said: \"[Ettenberg's] deep and thoughtful strategic legal leadership strengthens our ability to execute and accelerate value creation for our shareholders.\n\nAdvertisement\n\n\"As we continue to build upon our commercial foundation and invest in our pipeline, Felecia's proven skill navigating complex regulatory environments and partnering across the business will be critical. We are confident she will play a key role in advancing our growth strategy while staying true to our commitment to patients.\"\n\nEttenberg arrives after almost 25 years at Bristol Myers Squibb, working across a number of legal roles. She took up her current role two years ago, having...",
    "summary": "Ettenberg leaves Bristol-Myers Squibb Co as deputy general counsel for pipeline to patient global law.",
    "category": "leaves",
    "found_at": "2026-04-24T00:00:00Z",
    "planning": false,
    "image_url": "https://www-globallegalpost-static.s3.eu-west-2.amazonaws.com/images/2026AprFriWaltham.jpg",
    "job_title": "deputy general counsel for pipeline to patient global law",
    "confidence": 0.6044,
    "assets_tags": [
      "energy"
    ],
    "product_tags": [
      "medical"
    ],
    "published_at": "2026-04-24T00:00:00Z",
    "article_sentence": "Ettenberg joins from Bristol Myers Squibb, where she was deputy general counsel for pipeline to patient global law."
  }
}

curl https://signals.autobound.ai/v1/signals/a73fda3c-f9be-4877-b370-45771769cfaf \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"bms.com","limit":20}'